Are peptides third-party tested in Australia, or sent overseas?

Both happen. Testing done by an Australian laboratory is easier to verify — you can contact them, and the turnaround is short enough that reports stay current rather than being years old. Our independent purity and endotoxin reports are issued by Ozcanium Analytics, an Australian laboratory, and are published in full on the compound pages they cover rather than sent on request.

Third-Party Tested Peptides in Australia: What It Means and How to Verify It

Q: What tests does an independent peptide laboratory actually run?

Typically two, commissioned separately. Purity and identity by HPLC and mass spectrometry — the same methods a supplier COA uses, which is what makes the two directly comparable. And endotoxin by the LAL (Limulus Amebocyte Lysate) assay, reported in endotoxin units per milligram, which matters for any cell-culture or in-vivo model because lipopolysaccharide contamination confounds results at concentrations far below anything visible.

Q: How can I check a third-party report is genuine?

Look for four things: the laboratory is named and independently contactable; the report carries a test date; it carries a reference or verification code that the issuing laboratory will confirm against their own records; and the document is a real text PDF rather than an image pasted into a template. A report you can only obtain from the supplier, with no way to confirm it with the laboratory that supposedly wrote it, is an assertion in the shape of evidence.

Q: Does every peptide need independent testing?

Independent verification is most valuable where the consequence of being wrong is highest — a compound going into a cell-culture model, a long or difficult synthesis where impurity profiles vary between production runs, or any material where endotoxin load matters. In practice most suppliers apply it to a selection of their range rather than to everything, which is why it matters that a supplier states exactly which compounds are covered rather than making a blanket claim.

Compiled by the Tested Peptides Research TeamSourced from analytical chemistry standards and pharmacopoeial methods.

Key Takeaways
The distinction is independence, not methodology: a third-party report and a supplier COA often run the same tests. What differs is who bears the cost of a failing result.
Know what a report covers: an independent report is commissioned per compound and re-tested periodically. It is dated, and it describes the material tested on that date rather than every production run.
Verifiability is the test of a test: a named laboratory, a test date, a redeemable reference code and a real document. Anything less is a claim.

Introduction

"Third-party tested" has become close to a default claim in the Australian research peptide market, which is precisely what makes it worth examining. The phrase carries real weight when it describes an independent laboratory issuing its own report, and almost none when it describes a supplier reprinting numbers they generated themselves.

This guide covers what independent testing establishes that a supplier's own Certificate of Analysis cannot, what the two standard assays actually measure, and — the practical part — how to tell a verifiable report from a decorative one.

What "Third-Party" Actually Changes

Both a supplier's in-house COA and an independent laboratory's report can run reverse-phase HPLC for purity and LC-MS for identity. Frequently they run exactly the same methods on exactly the same material. The analytical content is not what separates them.

What separates them is incentive. A supplier that assays its own batch and finds 94% purity against a ≥98% specification has an expensive decision to make. A contract laboratory that finds the same thing has a report to send and an invoice to raise. Independence is not a claim about better instruments; it is a claim about who absorbs the cost of an unwelcome number.

That framing also explains what independent testing does and does not answer. It establishes what a disinterested laboratory measured in the material it was sent, on the date it was tested — a statement about a compound at a point in time, not about every vial ever produced.

What a Per-Compound Report Can and Cannot Say

An independent report is commissioned per compound and re-run every month or few, replacing the previous document. A supplier's own Certificate of Analysis is typically issued per production batch and carries that batch's lot number, test date and document ID.

This distinction matters more than it first appears. Peptide synthesis varies between production runs — deletion sequences, incomplete couplings and oxidised forms are batch phenomena, not compound phenomena. An independent report on a compound tested in June says nothing specific about a batch synthesised in August, which is why the date on a report matters and why periodic re-testing is worth more than a single historical result.

The trade runs the other way too. A batch-specific document that a supplier writes about its own material is only as good as that supplier's willingness to report an unwelcome number — the incentive problem above. We publish the independent side only: Tested Peptides runs no in-house analysis and issues no certificates of its own. Testing is commissioned from Ozcanium Analytics per compound and repeated periodically, and our testing library publishes the current report in full for each compound the laboratory has tested.

For how to read an analytical document itself, see our guide to understanding Certificates of Analysis.

The Two Assays, and What Each One Rules Out

Independent peptide testing is normally commissioned as two separate pieces of work, referenced separately by the laboratory.

Purity and identity (HPLC + mass spectrometry)

Reverse-phase HPLC separates everything in the vial by hydrophobicity and integrates it. The purity figure is the target peak's area as a percentage of total integrated area. Mass spectrometry then confirms the molecular identity of that peak against the mass calculated from the target sequence.

Running both is what makes the result meaningful. Purity alone establishes that the material is predominantly one thing; identity alone establishes that the target compound is present. Only together do they establish that the material is predominantly the target compound — which is the claim a purity percentage is usually read as making. Our guide to HPLC in peptide quality control covers how the integration works and where the figures can mislead.

Endotoxin (LAL assay)

Endotoxins are lipopolysaccharides from the outer membrane of gram-negative bacteria. They survive the conditions that kill the bacteria that produced them, so a preparation can be sterile and still carry a significant endotoxin load. The Limulus Amebocyte Lysate assay is the standard method, described in pharmacopoeial monographs including USP General Chapter <85> and European Pharmacopoeia 2.6.14, and results are reported in endotoxin units per milligram.

This matters for any cell-culture or in-vivo model, because endotoxin triggers immune and inflammatory responses at concentrations far below anything that affects a chromatogram. A peptide can be 99.5% pure by HPLC and still confound an experiment through contamination that purity testing is not designed to detect. Endotoxin testing is the assay most often absent from a supplier's panel, and the one whose absence is least visible.

It is also the assay that applies to materials that are never assayed by HPLC at all: bacteriostatic water is not a peptide and has no purity chromatogram, but it is exactly the kind of preparation where endotoxin load is the relevant question.

How to Verify a Report Rather Than Trust One

Four checks, in rough order of how often they fail:

The laboratory is named and independently contactable. "Verified by an accredited third-party lab" without a name is not a verifiable statement. A named laboratory can be searched, contacted and asked whether they have a client by that name.

The report carries a test date. An undated report cannot be assessed for relevance. Independent testing that was current two years ago tells you about material that no longer exists.

There is a reference the laboratory will confirm. The strongest form is a verification code the issuing laboratory redeems against their own records, so the confirmation comes from them rather than from the party being checked. Ours are printed beside each document and redeemable in Ozcanium Analytics' own portal.

The document is a document. A real report is a text PDF with the laboratory's own layout, instrument parameters and method details. A screenshot of a chromatogram pasted into a supplier's template is not the laboratory's document; it is a supplier's rendering of one, and it can be edited without leaving a trace.

A fifth check is worth applying to any published purity figure at all: does the supplier publish the document, or only the number taken from it? A percentage with no report behind it asks you to accept a result you cannot inspect. We publish the laboratory's report itself, in full, rather than a figure lifted from it.

What This Looks Like in Practice in Australia

Australian suppliers vary widely, and the phrase "third-party tested" is used across the whole range. Some publish independent reports in full. Some hold them and send on request. Some use the phrase to describe their own in-house testing, which is not what it means.

Independent testing performed by an Australian laboratory has two practical advantages beyond the obvious one: it can be verified without an international phone call, and turnaround is short enough that reports stay current rather than ageing into irrelevance.

Our testing library lists exactly which compounds the laboratory has tested rather than making a blanket claim across the catalogue. Where a compound is covered, its reports are published in full on that compound's page and on its testing page, with their verification codes.

Frequently Asked Questions

What does third-party tested mean for research peptides? It means a laboratory with no commercial interest in the result analysed the material and issued its own report. The distinction that matters is independence, not the tests themselves — a supplier COA and an independent report can run identical methods, but only one is written by a party that loses nothing if the batch fails.

Is a supplier's own Certificate of Analysis worthless then? No. A supplier's own COA is usually issued per batch and carries the lot number on the vial, which a compound-level, periodic independent report does not. What it cannot offer is independence — it is written by the party that bears the cost of a failing result. The two answer different questions. Tested Peptides publishes independent reports only and issues no certificates of its own.

What tests does an independent peptide laboratory actually run? Typically purity and identity by HPLC and mass spectrometry, and endotoxin by the LAL assay reported in endotoxin units per milligram. The two are usually commissioned and referenced separately.

How can I check a third-party report is genuine? The laboratory is named and contactable; the report carries a test date; it carries a reference the laboratory will confirm against their own records; and it is a real text PDF rather than an image in a supplier's template.

Does every peptide need independent testing? It is most valuable where the consequence of being wrong is highest — cell-culture models, long or difficult syntheses, and anywhere endotoxin load matters. Most suppliers apply it to a selection of their range, which is why it matters that a supplier states exactly which compounds are covered rather than making a blanket claim.

References

United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test. — View source
European Directorate for the Quality of Medicines. European Pharmacopoeia 2.6.14: Bacterial Endotoxins. — View source
International Council for Harmonisation. ICH Q6A: Specifications — Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products. — View source
Mant, C.T. & Hodges, R.S. "HPLC of Peptides and Proteins: Methods and Protocols." Methods in Molecular Biology, vol. 251. — View source

⚠️ Medical & Regulatory Disclaimer:
The information provided in this academic article is intended exclusively for educational and laboratory research purposes. It does NOT constitute medical advice. Compounds discussed are strictly for in-vitro research and development only, and are not intended for human consumption, veterinary use, or clinical treatment. Always adhere to Australian Therapeutic Goods Administration (TGA) regulations and your institution's ethical guidelines when handling research chemicals.

Compounds Referenced